The preliminary cost also include $35 million to $40 million for related capacity expansions for ONEOK Partners' anticipated 50% interest in the Overland Pass Pipeline to transport the additional unfractionated
NGL volumes from the new Bakken Pipeline; and $110 million to $140 million to expand the partnership's fractionation capacity at Bushton, Kansas, by 60,000 barrels per day to accommodate the additional NGL volumes.
1 selling low-molecular weight heparin in the world, Lovenox(R) is obtained by alkaline degradation of heparin benzyl ester and is about one-third the molecular size of unfractionated
One of her own patients recently received subcutaneous unfractionated
heparin (UH), and she asks you to prescribe that for her because the copayment for the LMWH is prohibitive.
heparin is a less attractive option in these high-risk patients.
Table 16: World Historic Review for Unfractionated
Some $450 to $550 million will be used to build a 525-615-mile NGL pipeline that will transport 60,000 bpd of unfractionated
NGLs from the Bakken Shale south through western North Dakota and eastern Montana to Wyoming, where it will connect to the 760-mile Overland Pass Pipeline near Cheyenne, WY.
The number one selling low-molecular weight heparin in the world, Lovenox(R) is obtained by alkaline degradation of heparin benzyl ester and is about one-third the molecular size of unfractionated
There was no difference between LMW and unfractionated
PHILADELPHIA -- Fondaparinux, a synthetic anticoagulant, appears to be as safe and effective as a low-molecular-weight heparin or unfractionated
heparin for the initial treatment of symptomatic venous thromboembolism, Dr.
Patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI), or angioplasty, experienced nearly 50 percent less bleeding at 30 days and comparable mortality at one-year when treated with Angiox[R] (bivalirudin) alone compared to unfractionated
heparin or enoxaparin plus a glycoprotein IIb/IIIa inhibitor (GPI), according to data from the ACUITY trial.
Results of the PCI-ExTRACT-TIMI 25 study announced today at the World Congress of Cardiology-European Society of Cardiology 2006 in Barcelona, showed that among patients with ST-segment elevation myocardial infarction (STEMI) who initially received fibrinolytic therapy and adjunctive antithrombotic therapy with either enoxaparin or unfractionated
heparin and subsequently underwent PCI, the enoxaparin strategy reduced the risk of death or recurrent heart attacks during the treatment phase before PCI and this benefit persisted after PCI for up to 30 days.
ATLANTA -- The low-molecular-weight heparin enoxaparin was more effective than unfractionated
heparin as an adjunct to fibrinolytic therapy in patients with an acute myocardial infarction in a study with more than 20,000 patients.